Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nanette C Schloot

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Clinical Immunology (Orlando, Fla.)|October 5, 2013
DiaPep277® and immune intervention for treatment of type 1 diabetesNanette C Schloot, Irun R Cohen
Journal of Autoimmunity|September 12, 2009
Association of T-cell reactivity with beta-cell function in recent onset type 1 diabetes patientsChristian Pfleger, Guido Meierhoff, Hubert Kolb, et al.
Diabetologia|October 27, 2015
Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatmentR David Leslie, Jerry Palmer, Nanette C Schloot, et al.
Biochemical and Biophysical Research Communications|February 20, 2008
Deficient heat shock protein 70 response to stress in leukocytes at onset of type 1 diabetesVolker Burkart, Leif Germaschewski, Nanette C Schloot, et al.
Diabetes/Metabolism Research and Reviews|October 25, 2002
Cytokine detection by ELISPOT: relevance for immunological studies in type 1 diabetesGuido Meierhoff, Patrick A Ott, Paul V Lehmann, et al.
Diabetes|April 30, 2003
An association of autoantibody status and serum cytokine levels in type 1 diabetesPejman Hanifi-Moghaddam, Nanette C Schloot, Simone Kappler, et al.
BMC Medicine|December 9, 2021
Ketone bodies: from enemy to friend and guardian angelHubert Kolb, Kerstin Kempf, Martin Röhling, et al.
Journal of Diabetes Science and Technology|January 12, 2021
Digital Diabetes Management: A Literature Review of Smart Insulin PensLutz Heinemann, Oliver Schnell, Bernhard Gehr, et al.
Diabetes/Metabolism Research and Reviews|December 28, 2020
Increased spontaneous CCL2 (MCP-1) and CCL5 (RANTES) secretion in vitro in LADA compared to type 1 diabetes and type 2 diabetes: Action LADA 14Mark Ooms, Alexander Strom, Klaus Strassburger, et al.
Diabetes Research and Clinical Practice|December 25, 2018
Concentrated insulins in current clinical practiceNanette C Schloot, Robert C Hood, Sheila M Corrigan, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Clinical Immunology (Orlando, Fla.)|October 5, 2013
DiaPep277® and immune intervention for treatment of type 1 diabetesNanette C Schloot, Irun R Cohen
Journal of Autoimmunity|September 12, 2009
Association of T-cell reactivity with beta-cell function in recent onset type 1 diabetes patientsChristian Pfleger, Guido Meierhoff, Hubert Kolb, et al.
Diabetologia|October 27, 2015
Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatmentR David Leslie, Jerry Palmer, Nanette C Schloot, et al.
Biochemical and Biophysical Research Communications|February 20, 2008
Deficient heat shock protein 70 response to stress in leukocytes at onset of type 1 diabetesVolker Burkart, Leif Germaschewski, Nanette C Schloot, et al.
Diabetes/Metabolism Research and Reviews|October 25, 2002
Cytokine detection by ELISPOT: relevance for immunological studies in type 1 diabetesGuido Meierhoff, Patrick A Ott, Paul V Lehmann, et al.
Diabetes|April 30, 2003
An association of autoantibody status and serum cytokine levels in type 1 diabetesPejman Hanifi-Moghaddam, Nanette C Schloot, Simone Kappler, et al.
BMC Medicine|December 9, 2021
Ketone bodies: from enemy to friend and guardian angelHubert Kolb, Kerstin Kempf, Martin Röhling, et al.
Journal of Diabetes Science and Technology|January 12, 2021
Digital Diabetes Management: A Literature Review of Smart Insulin PensLutz Heinemann, Oliver Schnell, Bernhard Gehr, et al.
Diabetes/Metabolism Research and Reviews|December 28, 2020
Increased spontaneous CCL2 (MCP-1) and CCL5 (RANTES) secretion in vitro in LADA compared to type 1 diabetes and type 2 diabetes: Action LADA 14Mark Ooms, Alexander Strom, Klaus Strassburger, et al.
Diabetes Research and Clinical Practice|December 25, 2018
Concentrated insulins in current clinical practiceNanette C Schloot, Robert C Hood, Sheila M Corrigan, et al.
Pageof 6